CME Podcasts

Hot Seat: How Experts Are Integrating the Latest Practice-Changing Data Into Their Breast Cancer Clinics

February 2nd 2026

Tackling Oncologic Emergencies in Patients Treated With High-Dose Methotrexate

January 30th 2026

Medical Crossfire®: The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP Inhibition in Triple-Negative Breast Cancer

January 30th 2026

Cases and Conversations™: Transforming Small Cell Lung Cancer Treatment Through Emerging Evidence and Expert Insights

January 27th 2026

Precision in Practice: Advancing Prostate Cancer Care With PSMA-Directed Radioligand Therapy

January 26th 2026

Medical Crossfire™: Navigating the Expanding Arsenal of Endocrine Therapies for HR+/HER2– Metastatic Breast Cancer – How Can PROTAC ER Degradation Shift the Standard?

January 23rd 2026

Hot Seat: Converging Lines in the Management of RAS-Altered Cancers

January 22nd 2026

Medical Crossfire® From Frontline to Heavily Pretreated HR+/HER2- Metastatic Breast Cancer: Expert Perspectives on Optimizing the Expanding Treatment Armamentarium

January 20th 2026

Medical Crossfire®: Mastering the Nuances of Early-Stage HR+/HER2- Breast Cancer—Expert Perspectives on Applying Modern Treatment Paradigms

January 19th 2026

Show Me the Data™: Personalizing First-Line and Maintenance Therapy in HER2+ Metastatic Breast Cancer to Extend Survival and Elevate Quality of Life

January 16th 2026

Tumor Board: Advances in Managing EGFR-Mutant NSCLC: Applying Evidence Across the Disease Continuum

October 24th 2025

Expert Guidance on Frequently Asked Questions Regarding the Use of ADCs in TNBC

September 30th 2025

Expert Roundtable and Panel Discussions: Current and Future Landscape of TNBC

September 26th 2025

Evaluating the Latest Data and Ongoing Trials for Novel ADC Approaches in TNBC

September 23rd 2025

Establishing the Rationale for ADC and ICI Combinations in TNBC

September 22nd 2025

Dissecting Clinical Trial and Real-World Data for ADCs in TNBC

September 19th 2025

Breaking Down the Rationale for Targeting TROP2 in TNBC

September 16th 2025

Distinguishing Pathway to Precision for c-Met and MET Alterations in NSCLC

August 22nd 2025

42nd Annual Miami Breast Cancer Conference® Podcast: OncLive On Air CE, Powered by PER

June 27th 2025

Oncology PER® Spectives: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

June 5th 2025